Skip to Content


In the US, Temozolomide (temozolomide systemic) is a member of the drug class alkylating agents and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme, Melanoma and Melanoma - Metastatic.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic alkylating agent

Chemical Name

Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-metyl-4-oxo-

Foreign Names

  • Temozolomidum (Latin)
  • Temozolomid (German)
  • Témozolomide (French)
  • Temozolomida (Spanish)

Generic Names

  • Temozolomide (OS: USAN, BAN, JAN)
  • Témozolomide (OS: DCF)
  • BRN 5547136 (IS)
  • CCRG 81045 (IS: Cancer Research C.T.)
  • M & B 39831 (IS: MayBaker)
  • Methazolastone (IS)
  • NSC 362856 (IS)
  • SCH 52365 (IS: ScheringPlough)
  • Temozolomide (PH: USP 38)

Brand Names

  • Advecit
    Aegis, Cyprus
  • Blastomat
    Alvogen, Estonia; Alvogen, Croatia (Hrvatska); Alvogen, Hungary; Alvogen, Netherlands; Alvogen, Poland; Alvogen, Romania; Alvogen, Slovenia; Eirgen Pharma, Macedonia; EirGen Pharma Limited, Bosnia & Herzegowina
  • Brastoryn
    Romastru, Netherlands; Romastru, Romania
  • Diqing
    Tasly, China
  • Dralitem
    Medicamenta Ecuatoriana, Ecuador; Raffo, Argentina; Tecnofarma, Chile
  • Emzolam
    Miracalus, India
  • Glioz
    Dr. Reddy's, India
  • Lostris
    Hemofarm, Bosnia & Herzegowina
  • Nilactin
    AC Farma, Peru
  • Nogron
    EGIS, Bulgaria; Egis Pharmaceuticals, Poland
  • Onkmoeck
    STADA, Czech Republic
  • Orion Temozolomide
    Orion, Australia
  • Ridoca
    Aenorasis, Netherlands
  • Rubrum Asf
    Asofarma de Mexico, Mexico
  • Rumalar
    Tuteur, Argentina
  • Temaccord
    Douglas, New Zealand
  • Temazol
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska)
  • Temintas
    Accord, South Africa
  • Temizole
    Aspen, Australia
  • Temo
    Haupt Pharma, Israel
  • Temodal
    Essex, Lebanon; Merck, Canada; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Slovenia; MSD, Switzerland; MSD, China; MSD, Denmark; MSD, Finland; MSD, Ireland; MSD, Japan; MSD, Netherlands; MSD, Norway; MSD, Sweden; MSD, Thailand; MSD Belgium, Belgium; MSD Merck Sharp & Dohme, Turkey; MSD Pharma, Hungary; MSD SHARP & DOHME, Germany; Orion, China; Orion, Israel; Schering, Brazil; Schering, Georgia; Schering-Plough, Argentina; Schering-Plough, Czech Republic; Schering-Plough, Indonesia; Schering-Plough, Lithuania; Schering-Plough, Latvia; Schering-Plough, Mexico; Schering-Plough, Oman; Schering-Plough, Philippines; Schering-Plough, Serbia; Schering-Plough, Russian Federation; Schering-Plough, Slovakia; Schering-Plough, Taiwan; Schering-Plough, South Africa; Scherring, Egypt; SP Europe, Greece; SP Europe-B, Italy
  • Témodal
    MSD France, France
  • Temodar
    Merck Sharp & Dohme Corp., United States
  • Temola
    Dosa, Argentina
  • Temolon
    Celon, India
  • Temomedac
    Alfred E. Tiefenbacher, Lithuania; Gebro, Spain; Lamepro, Belgium; medac, Czech Republic; medac, Germany; medac, United Kingdom; medac, Greece; medac, Iceland; medac, Netherlands; medac, Poland; medac, Romania; medac, Slovakia
  • Temomid
    Koçak, Turkey
  • Temoside
    Laboratorios Biosano, Chile
  • Temostad
    STADA, Czech Republic; STADA, Hungary; STADA, Poland; STADA, Slovakia
  • Temozam
    Fresenius, Philippines
  • Temozol
    Intas, Philippines
  • Temozolomid Accord
    Accord Healthcare, Slovenia
  • Temozolomid HEXAL
    Hexal, Germany
  • Temozolomid Hospira
    Accord Healthcare, Slovenia; Hospira, Germany
  • Temozolomid Labatec
    Labatec Pharma, Switzerland
  • Temozolomid ratiopharm
    ratiopharm Arzneimittel, Austria
  • Temozolomid Ribosepharm
    Ribosepharm, Germany
  • Temozolomid Sandoz
    Sandoz, Slovenia
  • Temozolomid STADA
    PharmaCoDane, Denmark; PharmaCoDane, Sweden
  • Temozolomid Teva
    Teva, Germany; Teva, Greece
  • Temozolomida Glenmark
    Glenmark, Romania
  • Temozolomida Hexal
    Hexal, Portugal
  • Temozolomida HF
    STADA Hemofarm, Romania
  • Temozolomida Hospira
    Hospira, Spain; Hospira, Portugal
  • Temozolomida Sandoz
    Sandoz, Portugal; Sandoz, Romania
  • Temozolomida Stada
    Stada, Portugal
  • Temozolomida Sun
    Sun, Spain; Sun, Portugal
  • Temozolomida Teva
    Teva, Spain; Teva, Romania; Teva Pharma, Portugal
  • Temozolomide Accord
    Accord, Netherlands
  • Temozolomide Actavis
    Actavis, Netherlands; Actavis Group, Poland; Actavis UK, United Kingdom
  • Temozolomide Apotex
    Apotex, Netherlands
  • Temozolomide CF
    Centrafarm, Netherlands
  • Temozolomide EG
    Eurogenerics, Belgium
  • Temozolomide Fair Med
    Fair-Med, Malta
  • Temozolomide FAIR-MED
    Fair-Med, Netherlands; Fair-Med, Poland
  • Temozolomide Glenmark
    Genepharm, Bulgaria; Glenmark, Netherlands; Glenmark, Poland
  • Temozolomide Hexal
    Hexal, Lithuania; Hexal, Netherlands; Hexal Polska, Poland
  • Temozolomide Hospira
    Hospira, Czech Republic; Hospira, Lithuania; Hospira, Netherlands; Hospira, Poland; Hospira, Sweden; Hospira UK, United Kingdom
  • Temozolomide Lotus
    Lotus Lab, Netherlands
  • Temozolomide Mylan
    Mylan, Netherlands
  • Temozolomide Polpharma
    Polpharma, Netherlands; Polpharma, Poland
  • Temozolomide ratiopharm
    ratiopharm, Netherlands
  • Temozolomide Sandoz
    Sandoz, Czech Republic; Sandoz, Italy; Sandoz, Lithuania; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Poland; Sandoz, Sweden
  • Temozolomide Sun
    Sun, Czech Republic; Sun, Lithuania; Sun Pharma, Netherlands; Sun Pharma, Norway; SUN Pharmac.Italia, Italy; SUN Pharmaceutical, Sweden; Sun Pharmaceutical Industries, Hungary; Sun Pharmaceuticals UK, United Kingdom; Sun-Farm, Poland
  • Temozolomide SUN
    SUN Europe, Denmark
  • Témozolomide Sun
    SUN Pharma, France
  • Temozolomide Teva
    Haupt Pharma Amareg, Slovakia; Teva, Belgium; Teva, Czech Republic; Teva, Lithuania; Teva, Latvia; Teva, Netherlands; Teva, Sweden; Teva Italia, Italy; Teva Pharma, Slovenia; Teva Pharma BV, Hungary; Teva Pharmaceuticals, Poland
  • Témozolomide Teva
    Teva Santé, France
  • Temozolomide Zentiva
    Zentiva, United Kingdom
  • Temozolomid-ratiopharm
    ratiopharm, Germany; ratiopharm, Netherlands
  • Temozolomid-Teva
    Teva Pharma, Switzerland
  • Tezolamet
    Pharmazac SA, Greece
  • Tezulina
    Microsules Arg, Argentina
  • Tocitrap
    Laboratorio LKM, Georgia; LKM, Argentina
  • Varizolamida
    Varifarma, Argentina
  • Zolom
    Aspen, Argentina
  • Zolomide
    Techno, Bangladesh
  • Zuriphar
    Zurich Pharma, Mexico


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.